Investing.com -- The European Investment Bank Group (EIB Group) has invested €714 million in two BBVA securitization operations, enabling the bank to mobilize approximately €1.3 billion in financing.

The stablecoin issuer submitted an all-cash offer late Friday to acquire Exor’s 65.4% stake at €2.66 per share, valuing Juventus at roughly €1.1 billion. Exor moved quickly to dismiss the proposal, ...

Wedbush is “cognizant of amplified disruption from tectonic shifts in behavior across enterprises and consumers” as AI adoption accelerates. Against that backdrop, the firm identified three stocks it ...

Investing.com -- Germany has ordered 20 additional Airbus H145M helicopters, exercising an option that was part of a contract signed in December 2023. The H145M light combat helicopters will be used ...

The Paris-based group expects world oil demand to rise by 830,000 barrels a day in 2025, citing an improving macroeconomic ...

Hikma Pharmaceuticals PLC (LON:HIK) said that Riad Mishlawi has stepped down as Chief Executive Officer and from the company’s Board of Directors by mutual agreement.

Investing.com-- Bitcoin edged lower on Monday, trading below the $90,000 level as subdued risk appetite and a wait-and-see approach dominated trading ahead of a heavy week of economic data and central ...

Investing.com-- Gold prices rose in Asian trade on Monday, extending gains after hitting a near two-month high in the prior session as weakness in the dollar and Treasury yields, following less ...

Investing.com-- Alphabet’s (NASDAQ:GOOGL) Google has signed a solar power agreement in Malaysia as part of its push to secure clean electricity for its global operations, Bloomberg reported on Monday, ...

Investing.com -- iRobot Corporation (NASDAQ:IRBT) stock was poised to plunge approximately 70% on Monday after the consumer robotics company announced it had filed for Chapter 11 bankruptcy protection ...

The Series B financing round, co-led by Oak HC/FT and General Catalyst, values the company at $1.3 billion. This funding comes just three months after the startup’s previous round and brings its total ...

Investing.com -- Immunome (NASDAQ:IMNM) stock surged 30% after the biotechnology company announced positive topline results from its Phase 3 RINGSIDE trial of varegacestat in patients with desmoid ...